Cargando…

Diagnostics of rare disorders: whole-exome sequencing deciphering locus heterogeneity in telomere biology disorders

BACKGROUND: The telomere biology disorders (TBDs) include a range of multisystem diseases characterized by mucocutaneous symptoms and bone marrow failure. In dyskeratosis congenita (DKC), the clinical features of TBDs stem from the depletion of crucial stem cell populations in highly proliferative t...

Descripción completa

Detalles Bibliográficos
Autores principales: Trotta, Luca, Norberg, Anna, Taskinen, Mervi, Béziat, Vivien, Degerman, Sofie, Wartiovaara-Kautto, Ulla, Välimaa, Hannamari, Jahnukainen, Kirsi, Casanova, Jean-Laurent, Seppänen, Mikko, Saarela, Janna, Koskenvuo, Minna, Martelius, Timi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097299/
https://www.ncbi.nlm.nih.gov/pubmed/30115091
http://dx.doi.org/10.1186/s13023-018-0864-9
_version_ 1783348274135040000
author Trotta, Luca
Norberg, Anna
Taskinen, Mervi
Béziat, Vivien
Degerman, Sofie
Wartiovaara-Kautto, Ulla
Välimaa, Hannamari
Jahnukainen, Kirsi
Casanova, Jean-Laurent
Seppänen, Mikko
Saarela, Janna
Koskenvuo, Minna
Martelius, Timi
author_facet Trotta, Luca
Norberg, Anna
Taskinen, Mervi
Béziat, Vivien
Degerman, Sofie
Wartiovaara-Kautto, Ulla
Välimaa, Hannamari
Jahnukainen, Kirsi
Casanova, Jean-Laurent
Seppänen, Mikko
Saarela, Janna
Koskenvuo, Minna
Martelius, Timi
author_sort Trotta, Luca
collection PubMed
description BACKGROUND: The telomere biology disorders (TBDs) include a range of multisystem diseases characterized by mucocutaneous symptoms and bone marrow failure. In dyskeratosis congenita (DKC), the clinical features of TBDs stem from the depletion of crucial stem cell populations in highly proliferative tissues, resulting from abnormal telomerase function. Due to the wide spectrum of clinical presentations and lack of a conclusive laboratory test it may be challenging to reach a clinical diagnosis, especially if patients lack the pathognomonic clinical features of TBDs. METHODS: Clinical sequencing was performed on a cohort of patients presenting with variable immune phenotypes lacking molecular diagnoses. Hypothesis-free whole-exome sequencing (WES) was selected in the absence of compelling diagnostic hints in patients with variable immunological and haematological conditions. RESULTS: In four patients belonging to three families, we have detected five novel variants in known TBD-causing genes (DKC1, TERT and RTEL1). In addition to the molecular findings, they all presented shortened blood cell telomeres. These findings are consistent with the displayed TBD phenotypes, addressing towards the molecular diagnosis and subsequent clinical follow-up of the patients. CONCLUSIONS: Our results strongly support the utility of WES-based approaches for routine genetic diagnostics of TBD patients with heterogeneous or atypical clinical presentation who otherwise might remain undiagnosed. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13023-018-0864-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6097299
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60972992018-08-20 Diagnostics of rare disorders: whole-exome sequencing deciphering locus heterogeneity in telomere biology disorders Trotta, Luca Norberg, Anna Taskinen, Mervi Béziat, Vivien Degerman, Sofie Wartiovaara-Kautto, Ulla Välimaa, Hannamari Jahnukainen, Kirsi Casanova, Jean-Laurent Seppänen, Mikko Saarela, Janna Koskenvuo, Minna Martelius, Timi Orphanet J Rare Dis Research BACKGROUND: The telomere biology disorders (TBDs) include a range of multisystem diseases characterized by mucocutaneous symptoms and bone marrow failure. In dyskeratosis congenita (DKC), the clinical features of TBDs stem from the depletion of crucial stem cell populations in highly proliferative tissues, resulting from abnormal telomerase function. Due to the wide spectrum of clinical presentations and lack of a conclusive laboratory test it may be challenging to reach a clinical diagnosis, especially if patients lack the pathognomonic clinical features of TBDs. METHODS: Clinical sequencing was performed on a cohort of patients presenting with variable immune phenotypes lacking molecular diagnoses. Hypothesis-free whole-exome sequencing (WES) was selected in the absence of compelling diagnostic hints in patients with variable immunological and haematological conditions. RESULTS: In four patients belonging to three families, we have detected five novel variants in known TBD-causing genes (DKC1, TERT and RTEL1). In addition to the molecular findings, they all presented shortened blood cell telomeres. These findings are consistent with the displayed TBD phenotypes, addressing towards the molecular diagnosis and subsequent clinical follow-up of the patients. CONCLUSIONS: Our results strongly support the utility of WES-based approaches for routine genetic diagnostics of TBD patients with heterogeneous or atypical clinical presentation who otherwise might remain undiagnosed. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13023-018-0864-9) contains supplementary material, which is available to authorized users. BioMed Central 2018-08-17 /pmc/articles/PMC6097299/ /pubmed/30115091 http://dx.doi.org/10.1186/s13023-018-0864-9 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Trotta, Luca
Norberg, Anna
Taskinen, Mervi
Béziat, Vivien
Degerman, Sofie
Wartiovaara-Kautto, Ulla
Välimaa, Hannamari
Jahnukainen, Kirsi
Casanova, Jean-Laurent
Seppänen, Mikko
Saarela, Janna
Koskenvuo, Minna
Martelius, Timi
Diagnostics of rare disorders: whole-exome sequencing deciphering locus heterogeneity in telomere biology disorders
title Diagnostics of rare disorders: whole-exome sequencing deciphering locus heterogeneity in telomere biology disorders
title_full Diagnostics of rare disorders: whole-exome sequencing deciphering locus heterogeneity in telomere biology disorders
title_fullStr Diagnostics of rare disorders: whole-exome sequencing deciphering locus heterogeneity in telomere biology disorders
title_full_unstemmed Diagnostics of rare disorders: whole-exome sequencing deciphering locus heterogeneity in telomere biology disorders
title_short Diagnostics of rare disorders: whole-exome sequencing deciphering locus heterogeneity in telomere biology disorders
title_sort diagnostics of rare disorders: whole-exome sequencing deciphering locus heterogeneity in telomere biology disorders
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097299/
https://www.ncbi.nlm.nih.gov/pubmed/30115091
http://dx.doi.org/10.1186/s13023-018-0864-9
work_keys_str_mv AT trottaluca diagnosticsofraredisorderswholeexomesequencingdecipheringlocusheterogeneityintelomerebiologydisorders
AT norberganna diagnosticsofraredisorderswholeexomesequencingdecipheringlocusheterogeneityintelomerebiologydisorders
AT taskinenmervi diagnosticsofraredisorderswholeexomesequencingdecipheringlocusheterogeneityintelomerebiologydisorders
AT beziatvivien diagnosticsofraredisorderswholeexomesequencingdecipheringlocusheterogeneityintelomerebiologydisorders
AT degermansofie diagnosticsofraredisorderswholeexomesequencingdecipheringlocusheterogeneityintelomerebiologydisorders
AT wartiovaarakauttoulla diagnosticsofraredisorderswholeexomesequencingdecipheringlocusheterogeneityintelomerebiologydisorders
AT valimaahannamari diagnosticsofraredisorderswholeexomesequencingdecipheringlocusheterogeneityintelomerebiologydisorders
AT jahnukainenkirsi diagnosticsofraredisorderswholeexomesequencingdecipheringlocusheterogeneityintelomerebiologydisorders
AT casanovajeanlaurent diagnosticsofraredisorderswholeexomesequencingdecipheringlocusheterogeneityintelomerebiologydisorders
AT seppanenmikko diagnosticsofraredisorderswholeexomesequencingdecipheringlocusheterogeneityintelomerebiologydisorders
AT saarelajanna diagnosticsofraredisorderswholeexomesequencingdecipheringlocusheterogeneityintelomerebiologydisorders
AT koskenvuominna diagnosticsofraredisorderswholeexomesequencingdecipheringlocusheterogeneityintelomerebiologydisorders
AT marteliustimi diagnosticsofraredisorderswholeexomesequencingdecipheringlocusheterogeneityintelomerebiologydisorders